Search

everythinglearnresearchcommunity

for

Search:↓

Pramipexole can cause side effects like dizziness, sleepiness, hallucinations, and low blood pressure, and it's important to educate patients and keep doses low.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Finasteride may help reduce impulsivity caused by pramipexole.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Targeting the Smoothened receptor shows promise for treating certain cancers.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.